
Technology Sectors & Industries
Therapeutics
Filter


Use of Capsaicin/TRPV1 agonists for prevention of diabetic foot ulcers
Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patient suffering from diabetic peripheral neuropathy (DPN).

Microbiome therapeutics to inhibit the growth of CRE and VRE
A proposed microbiome therapeutic against CRE and VRE, comprising a synthetic microbial consortium and inhibitory metabolites.

Edmond Yau
Edmond joined Imperial in February 2022 as an Industry Partnerships and Commercialisation Executive. He primarily takes care of IP and licensing cases from the Faculty of Natural Sciences. Prior to joining Imperial, Edmond worked in Royal College of Art as...

Dr Amritha Nair
Dr Amritha Nair is an Industry Partnerships and Commercialisation Senior Executive in the Faculty of Medicine at Imperial College London. Amritha works across the entire innovation lifecycle from assessment, protection, and management of Intellectual property;...
Catch up: Affordable technologies for an ageing society
Imperial.Tech.Pitch: Affordable technologies for an ageing society centred on the premise that within 20 years, there will be 25% fewer taxpayers to pensioners in the UK than in 2020.

HKMT Inhibitors
HKMTi-1-005 is a dual G9A/EZH2 histone methyltransferase which reactivates epigenetically repressed genes and inhibits tumour cell growth.

Aptamer-based multiplex screening platform
A fully flexible, scalable and low-cost detection platform to sense multiple protein targets simultaneously by grafting specific sequences along the backbone of a double-stranded DNA carrier.

Imperial.tech.pitch events – learn more and sign up
Learn about our programme of events and sign up to be alerted for future events

Professor Joshua B. Edel
Sign up for updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.